论文部分内容阅读
目的:探讨茵栀黄联合蓝光治疗新生儿高间接胆红素血症的临床效果。方法:本研究于2013年1月~2014年1月将收治的84例新生儿高间接胆红素血症患儿按照随机数字表法随机分为研究组和对照组,其中对照组在基础治疗的同时给予蓝光治疗,而研究组则在基础治疗的同时给予茵栀黄联合蓝光治疗,比较两组患儿的临床治疗效果。结果:研究组患者中痊愈29例,占69.05%,有效11例,占26.19%,总有效率达95.24%;对照组患者中痊愈17例,占40.48%,有效14例,占33.33%,总有效率达73.81%;经统计分析发现研究组的治疗总有效率明显高于对照组,且差异具有统计学意义(x2=7.37,P<0.05)。结论:与单纯蓝光治疗相比较,茵栀黄联合蓝光治疗新生儿高间接胆红素血症疗效满意,退黄速度快,不良反应发生率低,值得临床推广使用。
Objective: To investigate the clinical effect of Yinzhihuang combined with blue light on neonatal indirect hyperbilirubinemia. Methods: From January 2013 to January 2014, 84 infants with high neonatal indirect hyperbilirubinaemia were randomly divided into study group and control group according to the random number table. The control group was treated with basic treatment While the study group was treated with Yinzhihuang combined with blue light treatment at the same time, the clinical treatment effect of the two groups was compared. Results: The study group cured 29 cases, accounting for 69.05%, effective in 11 cases, accounting for 26.19%, the total effective rate was 95.24%; in the control group, 17 cases were cured, accounting for 40.48%, effective in 14 cases, accounting for 33.33% The effective rate was 73.81%. The statistical analysis showed that the total effective rate of the study group was significantly higher than that of the control group (x2 = 7.37, P <0.05). Conclusion: Compared with pure blue light therapy, Yinzhihuang combined with blue light treatment of neonatal high indirect bilirubin is effective, yellowing rate is fast, the incidence of adverse reactions is low, worthy of clinical promotion and use.